Long Non-Coding, Micro, and Circular RNAs in Ovarian Cancer Metastasis: Pathways and Treatment Approaches

Gynaecologic cancer is a major cause of death for women and the most well-known ovarian cancer (OC) has a high mortality rate. Given that the majority of ovarian cancer deaths are caused by metastatic tumors that have spread to nearby tissues, several biological processes, including angiogenesis and...

Full description

Saved in:
Bibliographic Details
Published inReproductive sciences (Thousand Oaks, Calif.) Vol. 32; no. 9; pp. 2842 - 2863
Main Authors Gosia, Meeral, Doshi, Gaurav, Parab, Siddhi, Godad, Angel
Format Journal Article
LanguageEnglish
Published Cham Springer International Publishing 01.09.2025
Subjects
Animals
Embryology
Female
Gene Expression Regulation, Neoplastic
Gynecologic Oncology: Review
Humans
Medicine
Medicine & Public Health
MicroRNAs - genetics
MicroRNAs - metabolism
Neoplasm Metastasis
Obstetrics/Perinatology/Midwifery
Ovarian Neoplasms - genetics
Ovarian Neoplasms - metabolism
Ovarian Neoplasms - pathology
Ovarian Neoplasms - therapy
Reproductive Medicine
RNA, Circular - genetics
RNA, Circular - metabolism
RNA, Long Noncoding - genetics
RNA, Long Noncoding - metabolism
miRNA
lncRNA
circRNA
Non-coding RNA
Ovarian cancer
Online AccessGet full text
ISSN1933-7191
1933-7205
1933-7205
DOI10.1007/s43032-025-01948-x

Cover

Abstract Gynaecologic cancer is a major cause of death for women and the most well-known ovarian cancer (OC) has a high mortality rate. Given that the majority of ovarian cancer deaths are caused by metastatic tumors that have spread to nearby tissues, several biological processes, including angiogenesis and metastasis, have a role in the onset and course of these diseases. Numerous non-coding RNAs (ncRNAs) have been shown in recent studies to contribute to the invasion and metastasis of ovarian cancer by altering particular cellular pathways. Three forms of ncRNAs which are long non-coding RNAs, micro RNAs, and circular RNAs are the subjects of this review. miRNA is used as a potential biomarker such as miR-375 which is a serum exosome and also in therapeutics. lncRNA sponges with miRNA which sequesters and regulates tumor progression such as XIST miR-149-3p. circRNA targets proteins and regulates gene expression. This review provides an overview of the precise function of non-coding RNAs in the many pathways and molecular exchanges that contribute to the invasion and metastasis of malignancies. To increase the survival rate of OC patients, new approaches to ncRNA-targeted therapy are being utilised, including targeting lncRNAs and circRNAs and modulating the tumor microenvironment using exosomes.
AbstractList Gynaecologic cancer is a major cause of death for women and the most well-known ovarian cancer (OC) has a high mortality rate. Given that the majority of ovarian cancer deaths are caused by metastatic tumors that have spread to nearby tissues, several biological processes, including angiogenesis and metastasis, have a role in the onset and course of these diseases. Numerous non-coding RNAs (ncRNAs) have been shown in recent studies to contribute to the invasion and metastasis of ovarian cancer by altering particular cellular pathways. Three forms of ncRNAs which are long non-coding RNAs, micro RNAs, and circular RNAs are the subjects of this review. miRNA is used as a potential biomarker such as miR-375 which is a serum exosome and also in therapeutics. lncRNA sponges with miRNA which sequesters and regulates tumor progression such as XIST miR-149-3p. circRNA targets proteins and regulates gene expression. This review provides an overview of the precise function of non-coding RNAs in the many pathways and molecular exchanges that contribute to the invasion and metastasis of malignancies. To increase the survival rate of OC patients, new approaches to ncRNA-targeted therapy are being utilised, including targeting lncRNAs and circRNAs and modulating the tumor microenvironment using exosomes.
Gynaecologic cancer is a major cause of death for women and the most well-known ovarian cancer (OC) has a high mortality rate. Given that the majority of ovarian cancer deaths are caused by metastatic tumors that have spread to nearby tissues, several biological processes, including angiogenesis and metastasis, have a role in the onset and course of these diseases. Numerous non-coding RNAs (ncRNAs) have been shown in recent studies to contribute to the invasion and metastasis of ovarian cancer by altering particular cellular pathways. Three forms of ncRNAs which are long non-coding RNAs, micro RNAs, and circular RNAs are the subjects of this review. miRNA is used as a potential biomarker such as miR-375 which is a serum exosome and also in therapeutics. lncRNA sponges with miRNA which sequesters and regulates tumor progression such as XIST miR-149-3p. circRNA targets proteins and regulates gene expression. This review provides an overview of the precise function of non-coding RNAs in the many pathways and molecular exchanges that contribute to the invasion and metastasis of malignancies. To increase the survival rate of OC patients, new approaches to ncRNA-targeted therapy are being utilised, including targeting lncRNAs and circRNAs and modulating the tumor microenvironment using exosomes.Gynaecologic cancer is a major cause of death for women and the most well-known ovarian cancer (OC) has a high mortality rate. Given that the majority of ovarian cancer deaths are caused by metastatic tumors that have spread to nearby tissues, several biological processes, including angiogenesis and metastasis, have a role in the onset and course of these diseases. Numerous non-coding RNAs (ncRNAs) have been shown in recent studies to contribute to the invasion and metastasis of ovarian cancer by altering particular cellular pathways. Three forms of ncRNAs which are long non-coding RNAs, micro RNAs, and circular RNAs are the subjects of this review. miRNA is used as a potential biomarker such as miR-375 which is a serum exosome and also in therapeutics. lncRNA sponges with miRNA which sequesters and regulates tumor progression such as XIST miR-149-3p. circRNA targets proteins and regulates gene expression. This review provides an overview of the precise function of non-coding RNAs in the many pathways and molecular exchanges that contribute to the invasion and metastasis of malignancies. To increase the survival rate of OC patients, new approaches to ncRNA-targeted therapy are being utilised, including targeting lncRNAs and circRNAs and modulating the tumor microenvironment using exosomes.
Author Doshi, Gaurav
Godad, Angel
Gosia, Meeral
Parab, Siddhi
Author_xml – sequence: 1
  givenname: Meeral
  surname: Gosia
  fullname: Gosia, Meeral
  organization: Department of Pharmacology, SVKM’s Dr. Bhanuben Nanavati College of Pharmacy
– sequence: 2
  givenname: Gaurav
  surname: Doshi
  fullname: Doshi, Gaurav
  organization: Department of Pharmacology, SVKM’s Dr. Bhanuben Nanavati College of Pharmacy
– sequence: 3
  givenname: Siddhi
  surname: Parab
  fullname: Parab, Siddhi
  organization: Department of Pharmacology, SVKM’s Dr. Bhanuben Nanavati College of Pharmacy
– sequence: 4
  givenname: Angel
  orcidid: 0000-0001-8833-8943
  surname: Godad
  fullname: Godad, Angel
  email: angelgodad@gmail.com, angel.godad@bncp.ac.in
  organization: Department of Pharmacology, SVKM’s Dr. Bhanuben Nanavati College of Pharmacy
BackLink https://www.ncbi.nlm.nih.gov/pubmed/40815436$$D View this record in MEDLINE/PubMed
BookMark eNp9kUlPwzAQhS0EYv8DHJCPHBrwkjQxtypik8oiVM7WxJm0Rq1T7ATaf4-hwBFppJnD92Y07x2Qbdc6JOSEs3POWH4RUsmkSJjIEsZVWiSrLbLPlZRJLli2_TtzxffIQQivjGWpEsUu2UtZwbNUDveJHbduSh9al5Rtbd10QO-t8e2Agqtpab3p5-Dp88MoUOvo4zt4C46W4Ax6eo8dhFg2XNIn6GYfsA7fwolH6BboOjpaLn0LZobhiOw0MA94_NMPycv11aS8TcaPN3flaJwYyViXKFUgZMNKGMCmzlI0WW0MmNTkBQyrysiGD9EgNEIJgRU3vKmFEIZBlVcC5SE52-yNh996DJ1e2GBwPgeHbR-0FFLlRcFUFtHTH7SvFljrpbcL8Gv9a08ExAaIloTgsflDONNfGehNBjpmoL8z0KsokhtRiLCbotevbe9d_Pk_1SdkD4rF
Cites_doi 10.1038/nsmb.1824
10.1080/15476286.2019.1702283
10.1159/000490131
10.1158/2326-6066.CIR-22-0410
10.2147/OTT.S211413
10.1016/j.ygyno.2010.12.339
10.1186/s12943-024-01967-3
10.18632/oncotarget.8089
10.2147/OTT.S137107
10.1158/0008-5472.CAN-17-3014
10.1186/s13048-022-00988-0
10.1186/s12935-021-01985-x
10.1038/cmi.2014.30
10.1038/ng.3192
10.1016/j.bbrc.2014.05.053
10.1158/2326-6066.CIR-17-0479
10.1002/gcc.20356
10.1186/s13046-018-0793-4
10.1038/ncomms11150
10.2147/OTT.S207938
10.1111/jog.13053
10.1016/j.cell.2010.09.049
10.18632/oncotarget.22136
10.1186/s12943-022-01611-y
10.3389/fonc.2021.765458
10.1042/BSR20211494
10.1186/s13048-023-01170-w
10.2147/OTT.S266186
10.1186/s12935-022-02602-1
10.3390/cancers14225711
10.1007/s00018-016-2174-5
10.1016/j.repbio.2022.100702
10.1038/s41419-021-03486-1
10.1016/j.cell.2009.01.002
10.3389/fcell.2021.593677
10.1038/nature11928
10.1186/s12943-018-0870-5
10.3389/fonc.2021.783526
10.1016/j.omtn.2019.09.032
10.7150/jca.52234
10.1038/nrneph.2016.51
10.18632/aging.103388
10.3389/fmolb.2021.771835
10.1186/1479-5876-12-4
10.1186/s13048-018-0458-0
10.1186/s12943-023-01765-3
10.1038/s41419-022-04510-8
10.1007/s13277-014-2738-7
10.1038/onc.2015.492
10.2147/OTT.S213231
10.1186/s13048-021-00916-8
10.1016/j.yexcr.2017.07.030
10.1007/s11684-017-0518-7
10.2174/2211536607666180525102330
10.1007/s11356-021-13710-2
10.3892/mmr.2017.6956
10.1097/AOG.0000000000005211
10.1186/s12943-019-1080-5
10.3390/cancers13184617
10.3389/fchem.2020.00400
10.3892/or.2014.3046
10.3892/ijo.2018.4566
10.4049/jimmunol.1103175
10.1038/ncomms3977
10.1186/s13048-022-01025-w
10.1038/s41573-021-00219-z
10.1186/s13048-018-0477-x
10.1038/s41419-019-1604-3
10.1186/s13048-020-00664-1
10.1016/j.bbrc.2018.09.060
10.1038/nbt.2890
10.1201/9780429053016-15
10.3802/jgo.2022.33.e81
10.3389/fmolb.2024.1361601
10.1186/s13048-022-01002-3
10.20892/j.issn.2095-3941.2017.0174
10.1021/pr500908n
10.1038/nature10398
10.3892/or.2020.7895
10.3389/fonc.2014.00143
10.2147/CMAR.S267355
10.1186/s13048-022-00979-1
10.3389/fphar.2023.1194719
10.1186/s12885-024-12969-1
10.1016/j.ygyno.2013.07.094
10.1096/fj.10-172452
10.1186/s12943-017-0630-y
10.1038/s41598-023-45317-7
10.2147/OTT.S259033
10.1038/srep41330
10.18632/aging.103470
10.20517/cdr.2019.51
10.1002/jbt.23383
10.3389/fmed.2022.913549
10.1186/s13046-018-0906-0
10.2147/OTT.S114318
10.1016/j.biocel.2019.04.011
10.18632/aging.103706
10.5582/bst.2019.01021
10.1007/s10528-022-10227-2
10.1677/ERC-09-0203
10.3802/jgo.2020.31.e75
10.1186/s12935-020-01420-7
10.1186/s13046-019-1437-z
10.3389/fendo.2018.00402
10.7150/ijbs.28048
10.1038/cdd.2017.129
10.1007/s13277-014-2560-2
10.1080/23723556.2016.1187322
10.3892/or.2021.7990
10.1016/j.gendis.2022.04.007
10.1016/j.canlet.2022.01.011
10.1186/s12943-020-01163-z
10.3892/ijmm.2020.4634
10.1038/s41598-018-28519-2
10.3892/ijo.2015.2943
10.7150/thno.72471
10.3390/genes13112054
10.1186/s12885-021-09073-z
10.1073/pnas.1602532113
10.1080/10985549.2022.2160605
10.1007/s12032-016-0842-9
10.1038/sj.onc.1207808
10.1038/srep38983
10.1016/j.bbcan.2021.188584
10.1186/s12958-021-00860-8
10.1186/s13048-020-00685-w
10.1007/s43032-021-00717-w
10.1016/j.tjog.2014.07.005
10.1016/S0092-8674(01)00431-7
10.1038/s41419-018-0946-6
10.1016/j.bbrc.2020.03.024
10.18632/oncotarget.27246
10.1016/j.omto.2022.03.005
10.3892/ijmm.2018.3540
10.1002/ctm2.425
10.1080/15476286.2017.1391443
10.1016/j.molcel.2004.07.007
10.3390/ijms18061207
10.1089/omi.2017.0115
10.18632/aging.103668
10.3892/ijo.2015.3121
10.3892/ol.2017.6854
10.18632/oncotarget.8744
10.3390/cancers12123730
10.1016/j.gene.2017.09.012
10.18632/oncotarget.8412
10.1158/1078-0432.CCR-16-1402
10.1038/s41419-020-03358-0
10.1016/j.ccr.2012.12.020
10.2147/CMAR.S248560
10.1016/j.ajpath.2015.11.011
10.1038/nature11993
10.3389/fgene.2023.1102114
10.1261/rna.041814.113
10.1016/j.neo.2018.12.005
10.1002/path.4443
10.3389/fcvm.2021.646806
10.1002/cam4.5317
10.1146/annurev-genet-110711-155459
10.2147/OTT.S220700
10.3389/fgene.2022.784089
10.1186/1755-8794-2-21
10.7150/jca.35041
10.1186/s40364-020-00221-4
10.1515/cclm-2015-0329
10.1007/s12033-023-00773-4
10.1038/nmeth1079
10.21037/gs-20-811
10.1042/BSR20201627
10.1186/s12967-020-02320-0
10.3892/or.2018.6368
10.1158/1078-0432.CCR-06-2882
10.1158/1078-0432.CCR-13-0066
10.1016/j.actbio.2018.12.045
10.1186/s13048-019-0589-y
10.1186/s12943-022-01531-x
10.1158/1535-7163.MCT-23-0314
10.1158/1535-7163.MCT-19-0510
10.3724/abbs.2021022
10.3390/ijms24076392
ContentType Journal Article
Copyright The Author(s), under exclusive licence to Society for Reproductive Investigation 2025 Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
2025. The Author(s), under exclusive licence to Society for Reproductive Investigation.
Copyright_xml – notice: The Author(s), under exclusive licence to Society for Reproductive Investigation 2025 Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
– notice: 2025. The Author(s), under exclusive licence to Society for Reproductive Investigation.
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1007/s43032-025-01948-x
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1933-7205
EndPage 2863
ExternalDocumentID 40815436
10_1007_s43032_025_01948_x
Genre Journal Article
Review
GroupedDBID ---
-TM
01A
0R~
123
29P
2JY
4.4
406
53G
5VS
AACDK
AAHNG
AAJBT
AAJPV
AAQDB
AARDL
AASML
AATNV
AAUYE
ABAKF
ABAWP
ABBRH
ABCCA
ABDBE
ABECU
ABEIX
ABFSG
ABFWQ
ABJNI
ABMQK
ABRTQ
ABTEG
ABTKH
ABTMW
ACAOD
ACDSZ
ACDTI
ACDXX
ACGFS
ACHSB
ACMLO
ACOKC
ACRPL
ACSTC
ACZOJ
ADBBV
ADEBD
ADKNI
ADNMO
ADTPH
ADYCS
ADYFF
ADZZY
AEFQL
AEMSY
AENEX
AEQLS
AERKM
AESKC
AEUHG
AEWDL
AEZWR
AFBBN
AFDZB
AFEET
AFHIU
AFOHR
AFQWF
AFWMB
AGMZJ
AGQEE
AGQPQ
AHHFK
AHPBZ
AHWEU
AIGIU
AILAN
AIXLP
AJZVZ
ALMA_UNASSIGNED_HOLDINGS
AMXSW
AMYLF
ARTOV
ATHPR
AUTPY
AYAKG
AYFIA
AZFZN
B8M
BGNMA
CAG
COF
CS3
DPUIP
DU5
EBLON
EBS
EJD
EMOBN
F5P
FEDTE
FIGPU
FNLPD
GROUPED_SAGE_PREMIER_JOURNAL_COLLECTION
H13
HF~
HVGLF
HZ~
IKXTQ
IWAJR
J8X
JZLTJ
K.F
KOV
LLZTM
M41
M4Y
N9A
NPVJJ
NQJWS
NU0
O9-
P.B
PT4
ROL
RSV
S01
SAUOL
SCLPG
SCNPE
SDE
SFC
SJYHP
SNE
SNPRN
SOHCF
SOJ
SQCSI
SRMVM
SSLCW
TSG
UOJIU
UTJUX
ZMTXR
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
ID FETCH-LOGICAL-c300t-998ea56b2caefd54ec5dccac4c78a6bbc3f16eceaf2922eb1c1fd222c0ab7b2e3
ISSN 1933-7191
1933-7205
IngestDate Fri Sep 05 15:10:03 EDT 2025
Fri Sep 19 01:51:10 EDT 2025
Thu Sep 25 00:45:58 EDT 2025
Thu Sep 18 01:12:25 EDT 2025
IsPeerReviewed true
IsScholarly true
Issue 9
Keywords miRNA
lncRNA
circRNA
Non-coding RNA
Ovarian cancer
Language English
License 2025. The Author(s), under exclusive licence to Society for Reproductive Investigation.
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c300t-998ea56b2caefd54ec5dccac4c78a6bbc3f16eceaf2922eb1c1fd222c0ab7b2e3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
ObjectType-Review-3
content type line 23
ORCID 0000-0001-8833-8943
PMID 40815436
PQID 3239788095
PQPubID 23479
PageCount 22
ParticipantIDs proquest_miscellaneous_3239788095
pubmed_primary_40815436
crossref_primary_10_1007_s43032_025_01948_x
springer_journals_10_1007_s43032_025_01948_x
PublicationCentury 2000
PublicationDate 20250900
PublicationDateYYYYMMDD 2025-09-01
PublicationDate_xml – month: 9
  year: 2025
  text: 20250900
PublicationDecade 2020
PublicationPlace Cham
PublicationPlace_xml – name: Cham
– name: United States
PublicationTitle Reproductive sciences (Thousand Oaks, Calif.)
PublicationTitleAbbrev Reprod. Sci
PublicationTitleAlternate Reprod Sci
PublicationYear 2025
Publisher Springer International Publishing
Publisher_xml – name: Springer International Publishing
References C Lin (1948_CR146) 2020; 20
H Lin (1948_CR45) 2018; 8
S Sun (1948_CR142) 2021; 14
D Yang (1948_CR69) 2013; 23
AV Zamaraev (1948_CR10) 2021; 1876
R Ji (1948_CR25) 2020; 9
H Mozdarani (1948_CR91) 2020; 18
1948_CR140
J Liu (1948_CR120) 2017; 16
W Tian (1948_CR173) 2022; 13
J-J Qiu (1948_CR94) 2025; 46
CL Au Yeung (1948_CR180) 2016; 7
N Dahiya (1948_CR79) 2010; 17
Y Qiu (1948_CR123) 2022; 14
Y Gao (1948_CR130) 2019; 13
A Beg (1948_CR22) 2022; 15
1948_CR158
N Zhang (1948_CR132) 2020; 13
1948_CR38
1948_CR35
JM Lorenzen (1948_CR80) 2016; 12
A Chao (1948_CR23) 2014; 53
X Li (1948_CR151) 2020; 11
J Qiu (1948_CR95) 2016; 7
J Zhang (1948_CR51) 2018; 9
E Gov (1948_CR4) 2017; 21
1948_CR40
F Teng (1948_CR124) 2019; 112
W Zhang (1948_CR115) 2021; 45
1948_CR154
R Liu (1948_CR52) 2015; 47
D Mi (1948_CR39) 2016; 42
E Pasmant (1948_CR92) 2011; 25
Y Pan (1948_CR167) 2022; 22
A Staebler (1948_CR105) 2006; 45
S Ghafouri-Fard (1948_CR184) 2022; 22
Y Cao (1948_CR65) 2017; 359
1948_CR127
1948_CR128
1948_CR24
1948_CR129
M-A El (1948_CR93) 2010; 17
J Liu (1948_CR70) 2017; 16
CS Herrington (1948_CR2) 2020
P Charkhchi (1948_CR26) 2020; 12
KS Anderson (1948_CR9) 2015; 14
SU Schmitz (1948_CR13) 2016; 73
F Wang (1948_CR168) 2023; 11
H Liang (1948_CR66) 2018; 17
W Zhao (1948_CR62) 2019; 12
L Ge (1948_CR131) 2022; 15
1948_CR17
C Wei (1948_CR77) 2017; 637
M Kobayashi (1948_CR177) 2018; 11
J Li (1948_CR53) 2017; 7
J Hu (1948_CR145) 2018; 505
M Vernon (1948_CR48) 2020; 19
X Guan (1948_CR150) 2019; 18
P Ramalingam (1948_CR12) 2014; 20
1948_CR15
TB Hansen (1948_CR84) 2013; 495
H Zhou (1948_CR116) 2022; 54
WR Jeck (1948_CR121) 2014; 32
1948_CR16
H Wang (1948_CR171) 2024; 66
T Shuang (1948_CR97) 2024; 24
MS Ebert (1948_CR43) 2007; 4
G Natoli (1948_CR83) 2012; 46
F Bossaghzadeh (1948_CR114) 2022; 26
X Wu (1948_CR137) 2021; 14
L Wang (1948_CR21) 2024; 23
L Wei (1948_CR72) 2014; 35
L Zhang (1948_CR143) 2019; 18
B Zhou (1948_CR49) 2017; 11
1948_CR133
Y Qiu (1948_CR141) 2022; 14
H Liu (1948_CR63) 2017; 10
A Conte (1948_CR125) 2018; 7
B Kristjansdottir (1948_CR27) 2013; 131
Y Fu (1948_CR136) 2022; 15
P-W Choi (1948_CR29) 2017; 18
M Bullock (1948_CR176) 2015; 1
Y Guan (1948_CR107) 2007; 13
Y Xiao (1948_CR96) 2020; 8
1948_CR104
Q Xu (1948_CR148) 2020; 13
P Ferreira (1948_CR32) 2020; 11
A Grishok (1948_CR18) 2001; 106
J Zhou (1948_CR59) 2018; 6
S-G Wu (1948_CR161) 2021; 21
MK Iyer (1948_CR14) 2015; 47
1948_CR87
Z-H Zong (1948_CR149) 2019; 38
RJ Kurman (1948_CR3) 2016; 186
M Stevanovic (1948_CR111) 2023; 24
Q Tang (1948_CR89) 2018; 47
J Ding (1948_CR157) 2020; 12
M Meryet-Figuière (1948_CR101) 2016; 7
H Wang (1948_CR172) 2023; 16
1948_CR182
1948_CR90
H Wang (1948_CR162) 2022; 29
Y Wang (1948_CR67) 2014; 31
1948_CR187
M Davies (1948_CR42) 2022; 13
B Wang (1948_CR34) 2018; 37
H Wang (1948_CR103) 2016; 6
P Martini (1948_CR109) 2017; 23
L Zhao (1948_CR20) 2022; 29
L Wei (1948_CR33) 2020; 45
G Meister (1948_CR19) 2004; 15
M Sheng (1948_CR147) 2019; 23
J Chen (1948_CR31) 2011; 121
1948_CR118
1948_CR117
J Li (1948_CR98) 2022; 9
1948_CR113
M Niemira (1948_CR36) 2023; 13
G Park Bin (1948_CR74) 2019; 21
Y Pan (1948_CR78) 2016; 7
K-C Huang (1948_CR100) 2002; 1
1948_CR76
X Wang (1948_CR144) 2020; 12
J Zhou (1948_CR155) 2020; 12
J Xie (1948_CR61) 2014; 11
SK Gandham (1948_CR46) 2022; 25
D Tian (1948_CR81) 2010; 143
J Yang (1948_CR185) 2018; 15
M Winkle (1948_CR188) 2021; 20
FF Kirigin (1948_CR11) 2012; 188
W Burke (1948_CR8) 2023; 142
M Wu (1948_CR135) 2022; 21
J Gong (1948_CR156) 2020; 12
C Ying (1948_CR110) 2018; 15
M Li (1948_CR159) 2021; 12
H Fujiwara (1948_CR28) 2015; 36
Z Zhao (1948_CR183) 2022; 530
J George (1948_CR106) 2013; 19
M Salem (1948_CR55) 2018; 78
Z Huang (1948_CR75) 2019; 10
R Jiang (1948_CR112) 2021; 12
1948_CR5
1948_CR64
Y Wu (1948_CR166) 2023; 12
1948_CR6
Z-D Xiao (1948_CR86) 2016; 3
1948_CR7
F Yang (1948_CR44) 2021; 19
Z Zhang (1948_CR160) 2021; 12
X Li (1948_CR164) 2022; 60
1948_CR163
1948_CR1
1948_CR71
GSR Raju (1948_CR88) 2023; 22
L Zhan (1948_CR102) 2018; 37
R Rupaimoole (1948_CR57) 2016; 35
W Wang (1948_CR73) 2014; 449
Z Wei (1948_CR60) 2016; 33
M Guttman (1948_CR82) 2011; 477
T Kawakami (1948_CR99) 2004; 23
T Liu (1948_CR165) 2022; 15
W Liao (1948_CR174) 2019; 86
Q Cao (1948_CR30) 2014; 7
DP Bartel (1948_CR85) 2009; 136
M Kobayashi (1948_CR175) 2014; 12
E Chirshev (1948_CR47) 2021; 13
F Xu (1948_CR153) 2020; 526
1948_CR56
L Ning (1948_CR134) 2022; 22
X Chong (1948_CR138) 2022; 21
1948_CR179
PM Haverty (1948_CR108) 2009; 2
X Chen (1948_CR169) 2023; 43
X Gan (1948_CR152) 2020; 19
YY Su (1948_CR37) 2019; 12
L Qiu (1948_CR181) 2020; 46
1948_CR170
W Wang (1948_CR186) 2024; 23
S Memczak (1948_CR122) 2013; 495
M Tang (1948_CR58) 2017; 8
N Liu (1948_CR126) 2018; 22
Y Wang (1948_CR54) 2017; 24
Y Sun (1948_CR68) 2015; 235
S Oncul (1948_CR119) 2020; 17
O-L Braicu (1948_CR41) 2017; 10
H Zhou (1948_CR139) 2022; 12
J-J Qiu (1948_CR178) 2018; 14
A Parikh (1948_CR50) 2014; 5
References_xml – volume: 17
  start-page: 862
  year: 2010
  ident: 1948_CR93
  publication-title: Nat Struct Mol Biol
  doi: 10.1038/nsmb.1824
– volume: 17
  start-page: 1523
  year: 2020
  ident: 1948_CR119
  publication-title: RNA Biol
  doi: 10.1080/15476286.2019.1702283
– volume: 47
  start-page: 893
  year: 2018
  ident: 1948_CR89
  publication-title: Cell Physiol Biochem
  doi: 10.1159/000490131
– volume: 11
  start-page: 199
  year: 2023
  ident: 1948_CR168
  publication-title: Cancer Immunol Res
  doi: 10.1158/2326-6066.CIR-22-0410
– ident: 1948_CR133
  doi: 10.2147/OTT.S211413
– volume: 121
  start-page: 200
  year: 2011
  ident: 1948_CR31
  publication-title: Gynecol Oncol
  doi: 10.1016/j.ygyno.2010.12.339
– volume: 23
  start-page: 66
  year: 2024
  ident: 1948_CR21
  publication-title: Mol Cancer
  doi: 10.1186/s12943-024-01967-3
– volume: 7
  start-page: 44719
  year: 2016
  ident: 1948_CR101
  publication-title: Oncotarget
  doi: 10.18632/oncotarget.8089
– volume: 10
  start-page: 4225
  year: 2017
  ident: 1948_CR41
  publication-title: Onco Targets Ther
  doi: 10.2147/OTT.S137107
– volume: 78
  start-page: 4175
  year: 2018
  ident: 1948_CR55
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-17-3014
– volume: 15
  start-page: 58
  year: 2022
  ident: 1948_CR131
  publication-title: J Ovarian Res
  doi: 10.1186/s13048-022-00988-0
– volume: 21
  start-page: 277
  year: 2021
  ident: 1948_CR161
  publication-title: Cancer Cell Int
  doi: 10.1186/s12935-021-01985-x
– volume: 11
  start-page: 495
  year: 2014
  ident: 1948_CR61
  publication-title: Cell Mol Immunol
  doi: 10.1038/cmi.2014.30
– volume: 47
  start-page: 199
  year: 2015
  ident: 1948_CR14
  publication-title: Nat Genet
  doi: 10.1038/ng.3192
– volume: 449
  start-page: 432
  year: 2014
  ident: 1948_CR73
  publication-title: Biochem Biophys Res Commun
  doi: 10.1016/j.bbrc.2014.05.053
– volume: 6
  start-page: 1578
  year: 2018
  ident: 1948_CR59
  publication-title: Cancer Immunol Res
  doi: 10.1158/2326-6066.CIR-17-0479
– volume: 45
  start-page: 905
  year: 2006
  ident: 1948_CR105
  publication-title: Genes Chromosomes Cancer
  doi: 10.1002/gcc.20356
– volume: 37
  start-page: 120
  year: 2018
  ident: 1948_CR102
  publication-title: J Exp Clin Cancer Res
  doi: 10.1186/s13046-018-0793-4
– volume: 7
  start-page: 11150
  year: 2016
  ident: 1948_CR180
  publication-title: Nat Commun
  doi: 10.1038/ncomms11150
– ident: 1948_CR140
  doi: 10.2147/OTT.S207938
– volume: 42
  start-page: 1326
  year: 2016
  ident: 1948_CR39
  publication-title: J Obstetrics Gynaecol Res
  doi: 10.1111/jog.13053
– volume: 143
  start-page: 390
  year: 2010
  ident: 1948_CR81
  publication-title: Cell
  doi: 10.1016/j.cell.2010.09.049
– volume: 8
  start-page: 97464
  year: 2017
  ident: 1948_CR58
  publication-title: Oncotarget
  doi: 10.18632/oncotarget.22136
– volume: 23
  start-page: 7283
  year: 2019
  ident: 1948_CR147
  publication-title: Eur Rev Med Pharmacol Sci
– volume: 21
  start-page: 137
  year: 2022
  ident: 1948_CR135
  publication-title: Mol Cancer
  doi: 10.1186/s12943-022-01611-y
– ident: 1948_CR179
  doi: 10.3389/fonc.2021.765458
– ident: 1948_CR38
  doi: 10.1042/BSR20211494
– volume: 16
  start-page: 142
  year: 2023
  ident: 1948_CR172
  publication-title: J Ovarian Res
  doi: 10.1186/s13048-023-01170-w
– volume: 14
  start-page: 97
  year: 2021
  ident: 1948_CR137
  publication-title: Onco Targets Ther
  doi: 10.2147/OTT.S266186
– volume: 22
  start-page: 172
  year: 2022
  ident: 1948_CR184
  publication-title: Cancer Cell Int
  doi: 10.1186/s12935-022-02602-1
– volume: 14
  start-page: 5711
  issue: 22
  year: 2022
  ident: 1948_CR141
  publication-title: Cancers (Basel)
  doi: 10.3390/cancers14225711
– volume: 73
  start-page: 2491
  year: 2016
  ident: 1948_CR13
  publication-title: Cell Mol Life Sci
  doi: 10.1007/s00018-016-2174-5
– volume: 14
  start-page: 5711
  year: 2022
  ident: 1948_CR123
  publication-title: Cancers (Basel)
  doi: 10.3390/cancers14225711
– volume: 22
  year: 2022
  ident: 1948_CR167
  publication-title: Reprod Biol
  doi: 10.1016/j.repbio.2022.100702
– volume: 12
  start-page: 219
  year: 2021
  ident: 1948_CR160
  publication-title: Cell Death Dis
  doi: 10.1038/s41419-021-03486-1
– volume: 136
  start-page: 215
  year: 2009
  ident: 1948_CR85
  publication-title: Cell
  doi: 10.1016/j.cell.2009.01.002
– ident: 1948_CR117
  doi: 10.3389/fcell.2021.593677
– volume: 495
  start-page: 333
  year: 2013
  ident: 1948_CR122
  publication-title: Nature
  doi: 10.1038/nature11928
– volume: 17
  start-page: 119
  year: 2018
  ident: 1948_CR66
  publication-title: Mol Cancer
  doi: 10.1186/s12943-018-0870-5
– ident: 1948_CR87
  doi: 10.3389/fonc.2021.783526
– volume: 18
  start-page: 882
  year: 2019
  ident: 1948_CR150
  publication-title: Mol Ther Nucleic Acids
  doi: 10.1016/j.omtn.2019.09.032
– volume: 12
  start-page: 611
  year: 2021
  ident: 1948_CR159
  publication-title: J Cancer
  doi: 10.7150/jca.52234
– volume: 12
  start-page: 360
  year: 2016
  ident: 1948_CR80
  publication-title: Nat Rev Nephrol
  doi: 10.1038/nrneph.2016.51
– volume: 12
  start-page: 14080
  year: 2020
  ident: 1948_CR155
  publication-title: Aging
  doi: 10.18632/aging.103388
– ident: 1948_CR35
  doi: 10.3389/fmolb.2021.771835
– volume: 12
  start-page: 4
  year: 2014
  ident: 1948_CR175
  publication-title: J Transl Med
  doi: 10.1186/1479-5876-12-4
– volume: 11
  start-page: 81
  year: 2018
  ident: 1948_CR177
  publication-title: J Ovarian Res
  doi: 10.1186/s13048-018-0458-0
– volume: 22
  start-page: 65
  year: 2023
  ident: 1948_CR88
  publication-title: Mol Cancer
  doi: 10.1186/s12943-023-01765-3
– volume: 13
  start-page: 64
  year: 2022
  ident: 1948_CR173
  publication-title: Cell Death Dis
  doi: 10.1038/s41419-022-04510-8
– volume: 36
  start-page: 1045
  year: 2015
  ident: 1948_CR28
  publication-title: Tumor Biol
  doi: 10.1007/s13277-014-2738-7
– volume: 1
  start-page: 769
  year: 2002
  ident: 1948_CR100
  publication-title: Mol Cancer Ther
– volume: 35
  start-page: 4312
  year: 2016
  ident: 1948_CR57
  publication-title: Oncogene
  doi: 10.1038/onc.2015.492
– ident: 1948_CR71
  doi: 10.2147/OTT.S213231
– volume: 14
  start-page: 158
  year: 2021
  ident: 1948_CR142
  publication-title: J Ovarian Res
  doi: 10.1186/s13048-021-00916-8
– volume: 359
  start-page: 185
  year: 2017
  ident: 1948_CR65
  publication-title: Exp Cell Res
  doi: 10.1016/j.yexcr.2017.07.030
– volume: 11
  start-page: 214
  year: 2017
  ident: 1948_CR49
  publication-title: Front Med
  doi: 10.1007/s11684-017-0518-7
– volume: 1
  start-page: 53
  year: 2015
  ident: 1948_CR176
  publication-title: Noncoding RNA
– volume: 7
  start-page: 178
  year: 2018
  ident: 1948_CR125
  publication-title: MicroRNA
  doi: 10.2174/2211536607666180525102330
– volume: 29
  start-page: 19072
  year: 2022
  ident: 1948_CR162
  publication-title: Environ Sci Pollut Res
  doi: 10.1007/s11356-021-13710-2
– volume: 16
  start-page: 3379
  year: 2017
  ident: 1948_CR70
  publication-title: Mol Med Rep
  doi: 10.3892/mmr.2017.6956
– volume: 142
  start-page: 179
  year: 2023
  ident: 1948_CR8
  publication-title: Obstet Gynecol
  doi: 10.1097/AOG.0000000000005211
– volume: 18
  start-page: 144
  year: 2019
  ident: 1948_CR143
  publication-title: Mol Cancer
  doi: 10.1186/s12943-019-1080-5
– volume: 13
  start-page: 4617
  year: 2021
  ident: 1948_CR47
  publication-title: Cancers (Basel)
  doi: 10.3390/cancers13184617
– ident: 1948_CR24
  doi: 10.3389/fchem.2020.00400
– volume: 31
  start-page: 1905
  year: 2014
  ident: 1948_CR67
  publication-title: Oncol Rep
  doi: 10.3892/or.2014.3046
– ident: 1948_CR127
  doi: 10.3892/ijo.2018.4566
– volume: 188
  start-page: 3257
  year: 2012
  ident: 1948_CR11
  publication-title: J Immunol
  doi: 10.4049/jimmunol.1103175
– volume: 5
  start-page: 2977
  year: 2014
  ident: 1948_CR50
  publication-title: Nat Commun
  doi: 10.1038/ncomms3977
– volume: 15
  start-page: 95
  year: 2022
  ident: 1948_CR165
  publication-title: J Ovarian Res
  doi: 10.1186/s13048-022-01025-w
– volume: 20
  start-page: 629
  year: 2021
  ident: 1948_CR188
  publication-title: Nat Rev Drug Discov
  doi: 10.1038/s41573-021-00219-z
– volume: 12
  start-page: 6
  year: 2019
  ident: 1948_CR37
  publication-title: J Ovarian Res
  doi: 10.1186/s13048-018-0477-x
– volume: 10
  start-page: 372
  year: 2019
  ident: 1948_CR75
  publication-title: Cell Death Dis
  doi: 10.1038/s41419-019-1604-3
– volume: 13
  start-page: 64
  year: 2020
  ident: 1948_CR132
  publication-title: J Ovarian Res
  doi: 10.1186/s13048-020-00664-1
– volume: 505
  start-page: 222
  year: 2018
  ident: 1948_CR145
  publication-title: Biochem Biophys Res Commun
  doi: 10.1016/j.bbrc.2018.09.060
– volume: 32
  start-page: 453
  year: 2014
  ident: 1948_CR121
  publication-title: Nat Biotechnol
  doi: 10.1038/nbt.2890
– start-page: 405
  volume-title: Muir’s textbook of pathology
  year: 2020
  ident: 1948_CR2
  doi: 10.1201/9780429053016-15
– ident: 1948_CR104
  doi: 10.3802/jgo.2022.33.e81
– ident: 1948_CR6
  doi: 10.3389/fmolb.2024.1361601
– volume: 15
  start-page: 72
  year: 2022
  ident: 1948_CR22
  publication-title: J Ovarian Res
  doi: 10.1186/s13048-022-01002-3
– volume: 15
  start-page: 238
  year: 2018
  ident: 1948_CR110
  publication-title: Cancer Biol Med
  doi: 10.20892/j.issn.2095-3941.2017.0174
– volume: 14
  start-page: 578
  year: 2015
  ident: 1948_CR9
  publication-title: J Proteome Res
  doi: 10.1021/pr500908n
– volume: 477
  start-page: 295
  year: 2011
  ident: 1948_CR82
  publication-title: Nature
  doi: 10.1038/nature10398
– volume: 45
  start-page: 569
  year: 2020
  ident: 1948_CR33
  publication-title: Oncol Rep
  doi: 10.3892/or.2020.7895
– ident: 1948_CR7
  doi: 10.3389/fonc.2014.00143
– ident: 1948_CR113
  doi: 10.2147/CMAR.S267355
– volume: 15
  start-page: 66
  year: 2022
  ident: 1948_CR136
  publication-title: J Ovarian Res
  doi: 10.1186/s13048-022-00979-1
– ident: 1948_CR187
  doi: 10.3389/fphar.2023.1194719
– volume: 24
  start-page: 1213
  year: 2024
  ident: 1948_CR97
  publication-title: BMC Cancer
  doi: 10.1186/s12885-024-12969-1
– volume: 131
  start-page: 52
  year: 2013
  ident: 1948_CR27
  publication-title: Gynecol Oncol
  doi: 10.1016/j.ygyno.2013.07.094
– volume: 25
  start-page: 444
  year: 2011
  ident: 1948_CR92
  publication-title: FASEB J
  doi: 10.1096/fj.10-172452
– volume: 16
  start-page: 58
  year: 2017
  ident: 1948_CR120
  publication-title: Mol Cancer
  doi: 10.1186/s12943-017-0630-y
– volume: 13
  start-page: 19287
  year: 2023
  ident: 1948_CR36
  publication-title: Sci Rep
  doi: 10.1038/s41598-023-45317-7
– ident: 1948_CR158
  doi: 10.2147/OTT.S259033
– volume: 7
  start-page: 41330
  year: 2017
  ident: 1948_CR53
  publication-title: Sci Rep
  doi: 10.1038/srep41330
– volume: 12
  start-page: 14314
  year: 2020
  ident: 1948_CR156
  publication-title: Aging
  doi: 10.18632/aging.103470
– ident: 1948_CR15
  doi: 10.20517/cdr.2019.51
– ident: 1948_CR170
  doi: 10.1002/jbt.23383
– ident: 1948_CR5
  doi: 10.3389/fmed.2022.913549
– volume: 37
  start-page: 235
  year: 2018
  ident: 1948_CR34
  publication-title: J Exp Clin Cancer Res
  doi: 10.1186/s13046-018-0906-0
– volume: 10
  start-page: 2701
  year: 2017
  ident: 1948_CR63
  publication-title: Onco Targets Ther
  doi: 10.2147/OTT.S114318
– volume: 112
  start-page: 8
  year: 2019
  ident: 1948_CR124
  publication-title: Int J Biochem Cell Biol
  doi: 10.1016/j.biocel.2019.04.011
– volume: 12
  start-page: 19095
  year: 2020
  ident: 1948_CR144
  publication-title: Aging
  doi: 10.18632/aging.103706
– volume: 13
  start-page: 204
  year: 2019
  ident: 1948_CR130
  publication-title: Biosci Trends
  doi: 10.5582/bst.2019.01021
– volume: 60
  start-page: 2611
  year: 2022
  ident: 1948_CR164
  publication-title: Biochem Genet
  doi: 10.1007/s10528-022-10227-2
– volume: 17
  start-page: F77
  year: 2010
  ident: 1948_CR79
  publication-title: Endocr Relat Cancer
  doi: 10.1677/ERC-09-0203
– ident: 1948_CR128
  doi: 10.3802/jgo.2020.31.e75
– volume: 20
  start-page: 336
  year: 2020
  ident: 1948_CR146
  publication-title: Cancer Cell Int
  doi: 10.1186/s12935-020-01420-7
– volume: 38
  start-page: 437
  year: 2019
  ident: 1948_CR149
  publication-title: J Exp Clin Cancer Res
  doi: 10.1186/s13046-019-1437-z
– ident: 1948_CR16
  doi: 10.3389/fendo.2018.00402
– volume: 14
  start-page: 1960
  year: 2018
  ident: 1948_CR178
  publication-title: Int J Biol Sci
  doi: 10.7150/ijbs.28048
– volume: 24
  start-page: 2089
  year: 2017
  ident: 1948_CR54
  publication-title: Cell Death Differ
  doi: 10.1038/cdd.2017.129
– volume: 35
  start-page: 12427
  year: 2014
  ident: 1948_CR72
  publication-title: Tumor Biol
  doi: 10.1007/s13277-014-2560-2
– volume: 3
  year: 2016
  ident: 1948_CR86
  publication-title: Mol Cell Oncol
  doi: 10.1080/23723556.2016.1187322
– volume: 45
  start-page: 39
  year: 2021
  ident: 1948_CR115
  publication-title: Oncol Rep
  doi: 10.3892/or.2021.7990
– volume: 9
  start-page: 1478
  year: 2022
  ident: 1948_CR98
  publication-title: Genes Dis
  doi: 10.1016/j.gendis.2022.04.007
– volume: 530
  start-page: 45
  year: 2022
  ident: 1948_CR183
  publication-title: Cancer Lett
  doi: 10.1016/j.canlet.2022.01.011
– volume: 19
  start-page: 45
  year: 2020
  ident: 1948_CR152
  publication-title: Mol Cancer
  doi: 10.1186/s12943-020-01163-z
– volume: 46
  start-page: 609
  year: 2020
  ident: 1948_CR181
  publication-title: Int J Mol Med
  doi: 10.3892/ijmm.2020.4634
– volume: 8
  start-page: 10461
  year: 2018
  ident: 1948_CR45
  publication-title: Sci Rep
  doi: 10.1038/s41598-018-28519-2
– volume: 46
  start-page: 2497
  year: 2025
  ident: 1948_CR94
  publication-title: Int J Oncol
  doi: 10.3892/ijo.2015.2943
– volume: 12
  start-page: 6069
  year: 2022
  ident: 1948_CR139
  publication-title: Theranostics
  doi: 10.7150/thno.72471
– volume: 13
  start-page: 2054
  year: 2022
  ident: 1948_CR42
  publication-title: Genes (Basel)
  doi: 10.3390/genes13112054
– volume: 22
  start-page: 6
  year: 2022
  ident: 1948_CR134
  publication-title: BMC Cancer
  doi: 10.1186/s12885-021-09073-z
– volume: 22
  start-page: 3713
  year: 2018
  ident: 1948_CR126
  publication-title: Eur Rev Med Pharmacol Sci
– ident: 1948_CR17
  doi: 10.1073/pnas.1602532113
– volume: 43
  start-page: 22
  year: 2023
  ident: 1948_CR169
  publication-title: Mol Cell Biol
  doi: 10.1080/10985549.2022.2160605
– volume: 33
  start-page: 126
  year: 2016
  ident: 1948_CR60
  publication-title: Med Oncol
  doi: 10.1007/s12032-016-0842-9
– volume: 23
  start-page: 6163
  year: 2004
  ident: 1948_CR99
  publication-title: Oncogene
  doi: 10.1038/sj.onc.1207808
– volume: 6
  start-page: 38983
  year: 2016
  ident: 1948_CR103
  publication-title: Sci Rep
  doi: 10.1038/srep38983
– volume: 26
  start-page: 77
  year: 2022
  ident: 1948_CR114
  publication-title: Iran Biomed J
– volume: 1876
  start-page: 188584
  year: 2021
  ident: 1948_CR10
  publication-title: Biochimica et Biophysica Acta (BBA) - Rev Cancer
  doi: 10.1016/j.bbcan.2021.188584
– volume: 19
  start-page: 178
  year: 2021
  ident: 1948_CR44
  publication-title: Reprod Biol Endocrinol
  doi: 10.1186/s12958-021-00860-8
– volume: 13
  start-page: 81
  year: 2020
  ident: 1948_CR148
  publication-title: J Ovarian Res
  doi: 10.1186/s13048-020-00685-w
– volume: 29
  start-page: 2760
  year: 2022
  ident: 1948_CR20
  publication-title: Reprod Sci
  doi: 10.1007/s43032-021-00717-w
– volume: 53
  start-page: 536
  year: 2014
  ident: 1948_CR23
  publication-title: Taiwan J Obstet Gynecol
  doi: 10.1016/j.tjog.2014.07.005
– volume: 106
  start-page: 23
  year: 2001
  ident: 1948_CR18
  publication-title: Cell
  doi: 10.1016/S0092-8674(01)00431-7
– volume: 9
  start-page: 884
  year: 2018
  ident: 1948_CR51
  publication-title: Cell Death Dis
  doi: 10.1038/s41419-018-0946-6
– volume: 526
  start-page: 14
  year: 2020
  ident: 1948_CR153
  publication-title: Biochem Biophys Res Commun
  doi: 10.1016/j.bbrc.2020.03.024
– volume: 11
  start-page: 1085
  year: 2020
  ident: 1948_CR32
  publication-title: Oncotarget
  doi: 10.18632/oncotarget.27246
– volume: 25
  start-page: 57
  year: 2022
  ident: 1948_CR46
  publication-title: Mol Ther Oncolytics
  doi: 10.1016/j.omto.2022.03.005
– ident: 1948_CR76
  doi: 10.3892/ijmm.2018.3540
– ident: 1948_CR182
  doi: 10.1002/ctm2.425
– volume: 15
  start-page: 35
  year: 2018
  ident: 1948_CR185
  publication-title: RNA Biol
  doi: 10.1080/15476286.2017.1391443
– volume: 15
  start-page: 185
  year: 2004
  ident: 1948_CR19
  publication-title: Mol Cell
  doi: 10.1016/j.molcel.2004.07.007
– volume: 18
  start-page: 1207
  year: 2017
  ident: 1948_CR29
  publication-title: Int J Mol Sci
  doi: 10.3390/ijms18061207
– volume: 21
  start-page: 603
  year: 2017
  ident: 1948_CR4
  publication-title: OMICS
  doi: 10.1089/omi.2017.0115
– volume: 12
  start-page: 17209
  year: 2020
  ident: 1948_CR157
  publication-title: Aging
  doi: 10.18632/aging.103668
– volume: 47
  start-page: 1429
  year: 2015
  ident: 1948_CR52
  publication-title: Int J Oncol
  doi: 10.3892/ijo.2015.3121
– ident: 1948_CR64
  doi: 10.3892/ol.2017.6854
– volume: 7
  start-page: 32478
  year: 2016
  ident: 1948_CR95
  publication-title: Oncotarget
  doi: 10.18632/oncotarget.8744
– volume: 12
  start-page: 3730
  year: 2020
  ident: 1948_CR26
  publication-title: Cancers (Basel)
  doi: 10.3390/cancers12123730
– volume: 637
  start-page: 25
  year: 2017
  ident: 1948_CR77
  publication-title: Gene
  doi: 10.1016/j.gene.2017.09.012
– volume: 7
  start-page: 25930
  year: 2016
  ident: 1948_CR78
  publication-title: Oncotarget
  doi: 10.18632/oncotarget.8412
– volume: 23
  start-page: 2356
  year: 2017
  ident: 1948_CR109
  publication-title: Clin Cancer Res
  doi: 10.1158/1078-0432.CCR-16-1402
– volume: 12
  start-page: 145
  year: 2021
  ident: 1948_CR112
  publication-title: Cell Death Dis
  doi: 10.1038/s41419-020-03358-0
– volume: 23
  start-page: 186
  year: 2013
  ident: 1948_CR69
  publication-title: Cancer Cell
  doi: 10.1016/j.ccr.2012.12.020
– ident: 1948_CR154
  doi: 10.2147/CMAR.S248560
– volume: 186
  start-page: 733
  year: 2016
  ident: 1948_CR3
  publication-title: Am J Pathol
  doi: 10.1016/j.ajpath.2015.11.011
– volume: 495
  start-page: 384
  year: 2013
  ident: 1948_CR84
  publication-title: Nature
  doi: 10.1038/nature11993
– ident: 1948_CR1
  doi: 10.3389/fgene.2023.1102114
– volume: 20
  start-page: 76
  year: 2014
  ident: 1948_CR12
  publication-title: RNA
  doi: 10.1261/rna.041814.113
– volume: 21
  start-page: 206
  year: 2019
  ident: 1948_CR74
  publication-title: Neoplasia
  doi: 10.1016/j.neo.2018.12.005
– volume: 235
  start-page: 25
  year: 2015
  ident: 1948_CR68
  publication-title: J Pathol
  doi: 10.1002/path.4443
– ident: 1948_CR118
  doi: 10.3389/fcvm.2021.646806
– volume: 12
  start-page: 5736
  year: 2023
  ident: 1948_CR166
  publication-title: Cancer Med
  doi: 10.1002/cam4.5317
– volume: 46
  start-page: 1
  year: 2012
  ident: 1948_CR83
  publication-title: Annu Rev Genet
  doi: 10.1146/annurev-genet-110711-155459
– ident: 1948_CR129
  doi: 10.2147/OTT.S220700
– ident: 1948_CR163
  doi: 10.3389/fgene.2022.784089
– volume: 2
  start-page: 21
  year: 2009
  ident: 1948_CR108
  publication-title: BMC Med Genomics
  doi: 10.1186/1755-8794-2-21
– volume: 11
  start-page: 599
  year: 2020
  ident: 1948_CR151
  publication-title: J Cancer
  doi: 10.7150/jca.35041
– volume: 8
  start-page: 41
  year: 2020
  ident: 1948_CR96
  publication-title: Biomark Res
  doi: 10.1186/s40364-020-00221-4
– ident: 1948_CR40
  doi: 10.1515/cclm-2015-0329
– volume: 66
  start-page: 1477
  year: 2024
  ident: 1948_CR171
  publication-title: Mol Biotechnol
  doi: 10.1007/s12033-023-00773-4
– volume: 7
  start-page: 2392
  year: 2014
  ident: 1948_CR30
  publication-title: Int J Clin Exp Pathol
– volume: 4
  start-page: 721
  year: 2007
  ident: 1948_CR43
  publication-title: Nat Methods
  doi: 10.1038/nmeth1079
– volume: 9
  start-page: 2175
  year: 2020
  ident: 1948_CR25
  publication-title: Gland Surg
  doi: 10.21037/gs-20-811
– ident: 1948_CR90
  doi: 10.1042/BSR20201627
– volume: 18
  start-page: 152
  year: 2020
  ident: 1948_CR91
  publication-title: J Transl Med
  doi: 10.1186/s12967-020-02320-0
– ident: 1948_CR56
  doi: 10.3892/or.2018.6368
– volume: 13
  start-page: 5745
  year: 2007
  ident: 1948_CR107
  publication-title: Clin Cancer Res
  doi: 10.1158/1078-0432.CCR-06-2882
– volume: 19
  start-page: 3474
  year: 2013
  ident: 1948_CR106
  publication-title: Clin Cancer Res
  doi: 10.1158/1078-0432.CCR-13-0066
– volume: 86
  start-page: 1
  year: 2019
  ident: 1948_CR174
  publication-title: Acta Biomater
  doi: 10.1016/j.actbio.2018.12.045
– volume: 12
  start-page: 121
  year: 2019
  ident: 1948_CR62
  publication-title: J Ovarian Res
  doi: 10.1186/s13048-019-0589-y
– volume: 21
  start-page: 118
  year: 2022
  ident: 1948_CR138
  publication-title: Mol Cancer
  doi: 10.1186/s12943-022-01531-x
– volume: 23
  start-page: 1666
  year: 2024
  ident: 1948_CR186
  publication-title: Mol Cancer Ther
  doi: 10.1158/1535-7163.MCT-23-0314
– volume: 19
  start-page: 1506
  year: 2020
  ident: 1948_CR48
  publication-title: Mol Cancer Ther
  doi: 10.1158/1535-7163.MCT-19-0510
– volume: 54
  start-page: 153
  year: 2022
  ident: 1948_CR116
  publication-title: Acta Biochim Biophys Sin (Shanghai)
  doi: 10.3724/abbs.2021022
– volume: 24
  start-page: 6392
  year: 2023
  ident: 1948_CR111
  publication-title: Int J Mol Sci
  doi: 10.3390/ijms24076392
SSID ssj0054928
Score 2.4261813
SecondaryResourceType review_article
Snippet Gynaecologic cancer is a major cause of death for women and the most well-known ovarian cancer (OC) has a high mortality rate. Given that the majority of...
SourceID proquest
pubmed
crossref
springer
SourceType Aggregation Database
Index Database
Publisher
StartPage 2842
SubjectTerms Animals
Embryology
Female
Gene Expression Regulation, Neoplastic
Gynecologic Oncology: Review
Humans
Medicine
Medicine & Public Health
MicroRNAs - genetics
MicroRNAs - metabolism
Neoplasm Metastasis
Obstetrics/Perinatology/Midwifery
Ovarian Neoplasms - genetics
Ovarian Neoplasms - metabolism
Ovarian Neoplasms - pathology
Ovarian Neoplasms - therapy
Reproductive Medicine
RNA, Circular - genetics
RNA, Circular - metabolism
RNA, Long Noncoding - genetics
RNA, Long Noncoding - metabolism
Title Long Non-Coding, Micro, and Circular RNAs in Ovarian Cancer Metastasis: Pathways and Treatment Approaches
URI https://link.springer.com/article/10.1007/s43032-025-01948-x
https://www.ncbi.nlm.nih.gov/pubmed/40815436
https://www.proquest.com/docview/3239788095
Volume 32
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1ba9swFBYhhbGXsfuyGxrsLXGwZfm2tzSsLWNJx5ZC34wsydQM7BI73eVP7i_t6OJLl22sezHBKHLi8-mcT0efjhB67clcsiRkThLnuQMMnDiMSF-d5p6Dv3RjHqkNzqt1eHJG350H56PRj4Fqaddkc_79t_tK_seqcA_sqnbJ3sCyXadwAz6DfeEKFobrP9n4vTooaF2VzrIS9mySlRLYtZLMZbE1MtOP64XWvZ5ewdQYRvRS2VoV8GkYsMO60Lq4D0AGv7BvpmjzphOgL2zVcSs2bIt5y0tTK1Ypj2wY1QnczUWlhD5ieso-m_IFavfXfJBxOK5qo9BdSZUQ66h0VesDhqfHbLdlV_3a1pbpNaNPhRAXRd-JYFaRaVW5be6CBJ0463ru8pfsZ5-AGzjmxPedyDMne83l4B5xg6E377Olu1avbl1zbMp42TBPYuNY90KIUY3UFGI7cfRv9hIaO1_7gNnJGLuSz7pxCo1T3VhNag5IBGRujA4WR4eH65YcqHp4sRE6mL9j93Hp3Zx7j7zOlfYmQHuL95oTbe6iO3YygxcGmffQSJb30a2VlWs8QIUCKO4BOsManjMM-MAtOLECJy5KbMGJDThxD843uIWm_mIHTdxD8yE6O3q7WZ449mwPh_uu2zgwy5csCDPCmcxFQCUPBDgTTnkUszDLuJ97oeSS5SQhBAgF93IBXJa7LIsy8CaP0LisSvkE4UiKIBQCQnsuaUI95lORRRFMNFwRc-5P0LR9i-mlKeGS_tlyE_SqfdEpeFq1fMZKCSMn9Qlwdwh3STBBj40Fuv4oMOuA-uEEzVqTpNZR1H952NObNX-Gbvej6DkaN9udfAGcuMleWpz9BDr6s1k
linkProvider Library Specific Holdings
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Long+Non-Coding%2C+Micro%2C+and+Circular+RNAs+in+Ovarian+Cancer+Metastasis%3A+Pathways+and+Treatment+Approaches&rft.jtitle=Reproductive+sciences+%28Thousand+Oaks%2C+Calif.%29&rft.au=Gosia%2C+Meeral&rft.au=Doshi%2C+Gaurav&rft.au=Parab%2C+Siddhi&rft.au=Godad%2C+Angel&rft.date=2025-09-01&rft.pub=Springer+International+Publishing&rft.issn=1933-7191&rft.eissn=1933-7205&rft.volume=32&rft.issue=9&rft.spage=2842&rft.epage=2863&rft_id=info:doi/10.1007%2Fs43032-025-01948-x&rft.externalDocID=10_1007_s43032_025_01948_x
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1933-7191&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1933-7191&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1933-7191&client=summon